Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
暂无分享,去创建一个
A. Cmelak | W. Westra | Sigui Li | J. Ridge | M. Gillison | A. Forastiere | C. Fakhry | H. Pinto
[1] R. Ferris,et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. , 2005, European journal of cancer.
[2] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[3] S. Franceschi,et al. Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer , 2004, Cancer Research.
[4] H. Dienes,et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. , 2003, The American journal of pathology.
[5] S. Franceschi,et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.
[6] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[7] K. Shah,et al. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[8] C. Peyton,et al. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. , 2003, Journal of virological methods.
[9] L. Mariani,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[11] R. Vollmer,et al. Basaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. , 1986, Human pathology.
[12] J. Laissue,et al. Human papillomavirus positive squamous cell carcinoma of the oropharynx , 2001, Cancer.
[13] G. Nuovo. Correspondence re: Huang C-C, Qui J-T, Kashima ML, Kurman RJ, Wu T-C. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol 1998;11:971-7. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[14] W. Miley,et al. A quantification of human cells using an ERV-3 real time PCR assay. , 2001, Journal of virological methods.
[15] G. Elmberger,et al. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. , 2005, Anticancer research.
[16] R. Kurman,et al. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[17] S. Schwartz,et al. Human Papillomavirus Infection and Survival in Oral Squamous Cell Cancer: A Population-Based Study , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[18] D. Rimm,et al. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M. Gillison,et al. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.
[20] W. McCluggage,et al. p16 Expression in the Female Genital Tract and Its Value in Diagnosis , 2006, Advances in anatomic pathology.
[21] A. Cmelak,et al. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] David R. Scott,et al. Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.
[23] M. Zahurak,et al. Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma , 2005, Clinical Cancer Research.
[24] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.